Literature DB >> 19846529

Interaction between Ebola virus glycoprotein and host toll-like receptor 4 leads to induction of proinflammatory cytokines and SOCS1.

Atsushi Okumura1, Paula M Pitha, Akihiko Yoshimura, Ronald N Harty.   

Abstract

Ebola virus initially targets monocytes and macrophages, which can lead to the release of proinflammatory cytokines and chemokines. These inflammatory cytokines are thought to contribute to the development of circulatory shock seen in fatal Ebola virus infections. Here we report that host Toll-like receptor 4 (TLR4) is a sensor for Ebola virus glycoprotein (GP) on virus-like particles (VLPs) and that resultant TLR4 signaling pathways lead to the production of proinflammatory cytokines and suppressor of cytokine signaling 1 (SOCS1) in a human monocytic cell line and in HEK293-TLR4/MD2 cells stably expressing the TLR4/MD2 complex. Ebola virus GP was found to interact with TLR4 by immunoprecipitation/Western blot analyses, and Ebola virus GP on VLPs was able to stimulate expression of NF-kappaB in a TLR4-dependent manner. Interestingly, we found that budding of Ebola virus VLPs was more pronounced in TLR4-stimulated cells than in unstimulated control cells. In sum, these findings identify the host innate immune protein TLR4 as a sensor for Ebola virus GP which may play an important role in the immunopathogenesis of Ebola virus infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19846529      PMCID: PMC2798428          DOI: 10.1128/JVI.01462-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Folate receptor alpha and caveolae are not required for Ebola virus glycoprotein-mediated viral infection.

Authors:  Graham Simmons; Andrew J Rennekamp; Ning Chai; Luk H Vandenberghe; James L Riley; Paul Bates
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

Review 2.  Are SOCS suppressors, regulators, and degraders?

Authors:  James A Johnston
Journal:  J Leukoc Biol       Date:  2003-12-23       Impact factor: 4.962

3.  Overlapping motifs (PTAP and PPEY) within the Ebola virus VP40 protein function independently as late budding domains: involvement of host proteins TSG101 and VPS-4.

Authors:  Jillian M Licata; Martha Simpson-Holley; Nathan T Wright; Ziying Han; Jason Paragas; Ronald N Harty
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

4.  Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes.

Authors:  T Kawai; O Takeuchi; T Fujita; J Inoue; P F Mühlradt; S Sato; K Hoshino; S Akira
Journal:  J Immunol       Date:  2001-11-15       Impact factor: 5.422

5.  Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus.

Authors:  L M Haynes; D D Moore; E A Kurt-Jones; R W Finberg; L J Anderson; R A Tripp
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

6.  Ebola virus-like particles protect from lethal Ebola virus infection.

Authors:  Kelly L Warfield; Catharine M Bosio; Brent C Welcher; Emily M Deal; Mansour Mohamadzadeh; Alan Schmaljohn; M Javad Aman; Sina Bavari
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-12       Impact factor: 11.205

7.  Contribution of ebola virus glycoprotein, nucleoprotein, and VP24 to budding of VP40 virus-like particles.

Authors:  Jillian M Licata; Reed F Johnson; Ziying Han; Ronald N Harty
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

8.  The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3.

Authors:  Christopher F Basler; Andrea Mikulasova; Luis Martinez-Sobrido; Jason Paragas; Elke Mühlberger; Mike Bray; Hans-Dieter Klenk; Peter Palese; Adolfo García-Sastre
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

9.  Ebola and Marburg virus-like particles activate human myeloid dendritic cells.

Authors:  Catharine M Bosio; Brian D Moore; Kelly L Warfield; Gordon Ruthel; Mansour Mohamadzadeh; M Javad Aman; Sina Bavari
Journal:  Virology       Date:  2004-09-01       Impact factor: 3.616

10.  Toll-like receptor 4-dependent activation of dendritic cells by a retrovirus.

Authors:  Dalia Burzyn; John C Rassa; David Kim; Irene Nepomnaschy; Susan R Ross; Isabel Piazzon
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

View more
  83 in total

1.  Human metapneumovirus glycoprotein G inhibits TLR4-dependent signaling in monocyte-derived dendritic cells.

Authors:  Deepthi Kolli; Xiaoyong Bao; Tianshuang Liu; Chao Hong; Tian Wang; Roberto P Garofalo; Antonella Casola
Journal:  J Immunol       Date:  2011-06-01       Impact factor: 5.422

Review 2.  Recent insights into the role of Toll-like receptors in viral infection.

Authors:  M Carty; A G Bowie
Journal:  Clin Exp Immunol       Date:  2010-09       Impact factor: 4.330

3.  Impact of Ebola mucin-like domain on antiglycoprotein antibody responses induced by Ebola virus-like particles.

Authors:  Osvaldo Martinez; Lee Tantral; Nirupama Mulherkar; Kartik Chandran; Christopher F Basler
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

4.  Type III secretion needle proteins induce cell signaling and cytokine secretion via Toll-like receptors.

Authors:  Danielle L Jessen; Patrick Osei-Owusu; Melody Toosky; William Roughead; David S Bradley; Matthew L Nilles
Journal:  Infect Immun       Date:  2014-03-18       Impact factor: 3.441

5.  The Induction of IL-1β Secretion Through the NLRP3 Inflammasome During Ebola Virus Infection.

Authors:  Peter Halfmann; Lindsay Hill-Batorski; Yoshihiro Kawaoka
Journal:  J Infect Dis       Date:  2018-11-22       Impact factor: 5.226

6.  Novel drugs targeting Toll-like receptors for antiviral therapy.

Authors:  Mira C Patel; Kari Ann Shirey; Lioubov M Pletneva; Marina S Boukhvalova; Alfredo Garzino-Demo; Stefanie N Vogel; Jorge Cg Blanco
Journal:  Future Virol       Date:  2014-09       Impact factor: 1.831

Review 7.  TLR4 Polymorphisms and Expression in Solid Cancers.

Authors:  Nilesh Pandey; Alex Chauhan; Neeraj Jain
Journal:  Mol Diagn Ther       Date:  2018-12       Impact factor: 4.074

8.  Ebolaviruses Associated with Differential Pathogenicity Induce Distinct Host Responses in Human Macrophages.

Authors:  Judith Olejnik; Adriana Forero; Laure R Deflubé; Adam J Hume; Whitney A Manhart; Andrew Nishida; Andrea Marzi; Michael G Katze; Hideki Ebihara; Angela L Rasmussen; Elke Mühlberger
Journal:  J Virol       Date:  2017-05-12       Impact factor: 5.103

Review 9.  Immune barriers of Ebola virus infection.

Authors:  Anita K McElroy; Elke Mühlberger; César Muñoz-Fontela
Journal:  Curr Opin Virol       Date:  2018-02-16       Impact factor: 7.090

10.  RNA helicase signaling is critical for type i interferon production and protection against Rift Valley fever virus during mucosal challenge.

Authors:  Megan E Ermler; Ekaterina Yerukhim; Jill Schriewer; Stefan Schattgen; Zachary Traylor; Adam R Wespiser; Daniel R Caffrey; Zhijian J Chen; Charles H King; Michael Gale; Marco Colonna; Katherine A Fitzgerald; R Mark L Buller; Amy G Hise
Journal:  J Virol       Date:  2013-02-13       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.